newsfilter
← Latest News
ACCESS Newswire·

Hemogenyx Pharmaceuticals PLC Announces Immuno-Oncology Summit Europe Presentation

LONDON, UK / ACCESSWIRE / May 16, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce its participation in the Immuno-Oncology Summit Europe 2022, at which Dr Vladislav Sandler will make a presentation entitled "Anti-FLT3 CAR-T and Bis